Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers115
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead87
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia80
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer80
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes63
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer58
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma57
An Update on Temporal Bone Paragangliomas56
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies55
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect47
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?46
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)46
Small Cell Lung Cancer—An Update on Chemotherapy Resistance42
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T41
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers39
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer38
The Role of Nursing in the Delivery of Cardio-Oncology38
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors37
Management of Fatigue in Patients with Advanced Cancer34
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma32
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?31
Approach to Localized Squamous Cell Cancer of the Esophagus31
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements30
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities30
Regorafenib for the Treatment of Sarcoma30
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer28
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations28
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?27
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer26
Advances in Targeted Therapy for Metastatic Prostate Cancer26
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management26
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?25
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia24
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs24
Recognition and Management of the Long-term Effects of Cranial Radiation23
Novel Approaches for the Treatment of Patients with Richter’s Syndrome23
Optimal Strategies for Colorectal Cancer Screening22
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?22
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia22
Gastric Cancer with Sarcopenia: an Area Worth Focusing On22
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas21
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond21
Response Evaluation of Neoadjuvant Therapies in Sarcoma21
Treatment Options for Brain Metastases21
Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities21
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities20
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors20
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review20
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment20
Contemporary Review of Adenocarcinoma of the Cervix20
Novel Estrogen Receptor-Targeted Agents for Breast Cancer20
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy20
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer19
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)18
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives18
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers18
Research Progress on Ferroptosis in Multiple Myeloma18
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer18
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms18
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis18
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract18
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia17
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects17
Updates in Management of Malignant Pleural Mesothelioma17
The Dilemma of Treating Delirium: the Conundrum of Drug Management17
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer17
Updates in Breast Cancer Screening and Diagnosis16
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma16
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives16
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation16
Progress in the Treatment of Small Intestine Cancer16
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer15
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy15
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations15
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective15
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease15
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?15
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer14
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus14
Correction to: Cardiotoxicity of Systemic Melanoma Treatments14
Advances in PSMA-Targeted Radionuclide Therapeutics14
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer14
The Role of SIRT1 in Leukemia13
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome13
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management13
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management13
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?13
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review13
Myxoid Liposarcomas: Systemic Treatment Options13
The Role of Induction Therapy for Sinonasal Cancers13
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer13
The Use of Targeted Agents in the Treatment of Gynecologic Cancers12
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches12
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming12
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance12
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology12
Advancements in Melanoma Therapies: From Surgery to Immunotherapy12
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions12
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation12
HER2-Positive Metastatic Colorectal Cancer12
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies12
Management of Functional Pancreatic Neuroendocrine Neoplasms12
Therapeutic Management of Malignant Wounds: An Update12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors12
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?12
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?12
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?11
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer11
Diagnosis and Treatment of Myxoid Liposarcoma11
Targeted Therapy in Early Stage Non-small Cell Lung Cancer11
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?11
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes11
Cardio-Oncology Care Delivered in the Non-academic Environment11
Nanomedicine-Based Treatments for Rare and Aggressive Ocular Cancers: Advances in Drug Delivery11
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?11
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy11
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer11
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic11
Community Palliative Care: What are the Best Models?11
Impact of PSMA PET on Prostate Cancer Management11
0.34682393074036